Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial

Infect Control Hosp Epidemiol. 2011 Sep;32(9):872-80. doi: 10.1086/661285.

Abstract

Background: Despite a paucity of evidence, decolonization measures are prescribed for outpatients with recurrent Staphylococcus aureus skin and soft-tissue infection (SSTI).

Objective: Compare the effectiveness of 4 regimens for eradicating S. aureus carriage.

Design: Open-label, randomized controlled trial. Colonization status and recurrent SSTI were ascertained at 1 and 4 months.

Setting: Barnes-Jewish and St. Louis Children's Hospitals, St. Louis, Missouri, 2007-2009.

Participants: Three hundred patients with community-onset SSTI and S. aureus colonization in the nares, axilla, or inguinal folds.

Interventions: Participants were randomized to receive no therapeutic intervention (control subjects) or one of three 5-day regimens: 2% mupirocin ointment applied to the nares twice daily, intranasal mupirocin plus daily 4% chlorhexidine body washes, or intranasal mupirocin plus daily dilute bleach water baths.

Results: Among 244 participants with 1-month colonization data, modified intention-to-treat analysis revealed S. aureus eradication in 38% of participants in the education only (control) group, 56% of those in the mupirocin group (P = .03 vs controls), 55% of those in the mupirocin and chlorhexidine group (P = .05), and 63% off those in the mupirocin and bleach group (P = .006). Of 229 participants with 4-month colonization data, eradication rates were 48% in the control group, 56% in the mupirocin only group (P = .40 vs controls), 54% in the mupirocin and chlorhexidine group (P = .51), and 71% in the mupirocin and bleach group (P = .02). At 1 and 4 months, recurrent SSTIs were reported by 20% and 36% of participants, respectively.

Conclusions: An inexpensive regimen of dilute bleach baths, intranasal mupirocin, and hygiene education effectively eradicated S. aureus over a 4-month period. High rates of recurrent SSTI suggest that factors other than endogenous colonization are important determinants of infection. Trial registration. ClinicalTrials.gov identifier: NCT00513799.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Infective Agents, Local / administration & dosage
  • Baths
  • Carrier State / drug therapy*
  • Child
  • Child, Preschool
  • Chlorhexidine / administration & dosage*
  • Combined Modality Therapy
  • Community-Acquired Infections / drug therapy
  • Female
  • Humans
  • Infant
  • Male
  • Mupirocin / administration & dosage*
  • Nose / microbiology
  • Patient Compliance
  • Patient Education as Topic
  • Sodium Hypochlorite / administration & dosage*
  • Soft Tissue Infections / drug therapy*
  • Soft Tissue Infections / therapy
  • Staphylococcal Skin Infections / drug therapy*
  • Staphylococcal Skin Infections / therapy
  • Staphylococcus aureus*
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents, Local
  • Mupirocin
  • Sodium Hypochlorite
  • Chlorhexidine

Associated data

  • ClinicalTrials.gov/NCT00513799